Simple Western webinars

Viewing tip:  During playback, use the "quality" button on the player control bar to choose the highest resolution and greatly increase the quality of the video.


Wes Gives You 100X More Dynamic Range with 3 µL Sample Volume

November 30, 2016
Bob Gavin, Senior VP, ProteinSimple
Chris Heger, Ph.D., Manager Applications Sciences, ProteinSimple

Generation of your protein sample took significant time and expense. You cannot afford to waste precious sample going through assay optimization only to find your protein is not there or it is overexposed. Chemiluminescence Western blot detection is the best option for sensitivity but playing the dynamic range optimization game takes times and burns through your sample. Learn how updates to Simple Western Wes reduce assay optimization time through a 100X improvement in dynamic range while requiring only 3 µl of your sample. In this webinar, we will present data showing how improvements to Wes limit substrate depletion enabling both ultra-high sensitivity and a 6 log dynamic range. If you already have Wes, you will learn how this can simply be done on your current system.


Rethink Immunoassays: The Simple Western is here

November 3, 2015
Bob Gavin, Senior VP, Protein Platforms, ProteinSimple
Chris Heger, Ph.D., Manager, Field Applications, ProteinSimple
Birte Aggeler, Director of Antibody Development, R&D Systems

Rethink the way you do immunoassays with Simple Western. It's the Western you know well, only simplified and completely reinvented. The Simple Western is the only gel-free, blot-free, hands-free Western workflow.

Watch this one-hour webinar to learn how it works and how you can get your time back by getting reproducible, quantitative data every time. Bob Gavin, our SVP of Protein Platforms, kicks off the discussion by introducing Simple Western and talk about Wes, our latest addition to the product family. You'll also hear from our Field Applications Manager, Chris Heger, on how scientists like yourselves have been using Simple Western to advance their research. And lastly, Birte Aggeler, Director of Antibody Development from R&D Systems, talks about the Simple Western-certified antibody project we've been working on with our sister brands, R&D Systems and Novus Biologicals. Don't miss the opportunity to hear from the brains behind Simple Western!


Neurobiological Markers of Cocaine Use Disorder

July 21, 2015
Dr. Noelle Anastasio, Assistant Professor, Dept. Pharmacology and Toxicology, University of Texas Medical Branch
Sarah Swinford-Jackson, Graduate Assistant, Center for Addiction Research, University of Texas Medical Branch

Cocaine use disorder is characterized by chronic cycles of abstinence and relapse; prevention and treatment of cocaine use disorder could be greatly advanced by a more comprehensive understanding of the neurobiological underpinnings. Alterations in the serotonin and glutamate neurotransmitter receptor systems in the brain are putative molecular mechanisms which may be involved in the propensity to relapse to cocaine use. We optimized and implemented a quantifiable and reproducible automated Simple Western assay in Wes™, to examine serotonin and glutamate receptor expression as well as protein:protein interactions from rodent brain samples.

During this webinar, Dr. Noelle Anastasio, Assistant Professor, Department of Pharmacology and Toxicology, University of Texas Medical Branch; and Sarah Swinford-Jackson, Graduate Assistant, Center for Addiction Research, University of Texas Medical Branch, will discuss:

  • Validation of commercially available antibodies in vitro and ex vivo for serotonin receptors using Wes—the gel-free, blot-free, hands-free automated Western system from ProteinSimple.
  • Investigation of serotonin and glutamate receptor expression in preclinical models of cocaine use disorder.
  • Exploration of serotonin receptor and glutamate receptor protein:protein interactions.


Protein Analysis Made Simple

March 17, 2015
Sarah Barry, Graduate Fellow, Jaqueline McGinty Lab, Neuroscience Institute, Medical University of South Carolina
Dr. Asimina Kerimi, Research Fellow, Gary Williamson Group, University of Leeds

Western blotting is a ubiquitous technique for protein analysis, but presents many challenges. Recent advances that fully automate the process have improved data quantification and reproducibility without using gels, blots, and manual analysis. This live webinar brings together a panel of experts to discuss how they are using this new technology to examine the molecular mechanism of cocaine addiction and to study the localization of proteins involved in small-molecule bioavailability. Don’t miss the chance to learn how to automate your protein research process and get more quantitative, reproducible data!

Topics to be covered:

  • The use of capillary electrophoresis for protein analysis
  • Multiplex protein detection
  • Detection and quantification of low abundance proteins


Revealing Parkinson's Disease and Traumatic Brain Injury Biomarkers with Simple Western

February 17, 2015
Lise Munsie, Ph.D., Postdoctoral Research Fellow Centre for Applied Neurogenetics, Medical Genetics. Univ. British Columbia
Ryan Hart, M.S., Barrow Neurological Institute at Phoenix Children's Hospital
Dan Griffiths, B.S., Barrow Neurological Institute at Phoenix Children's Hospital

The brain is a complex organ. As you can imagine, studying it is not a trivial task ­ particularly when looking at Parkinson¹s Disease or traumatic brain injury. Western blot has been traditionally used to study protein changes. However, it has limitations such as labor-intensive workflows and poor quality data. To get a comprehensive understanding of how proteins play a role in complex physiological events, these researchers have been using Simple Western, a complete reinvention of the old-school Western blot that is gel-free, blot-free, and hands-free. Simple Western offers highly reproducible and quantitative data in an automated platform, and it delivers fully analyzed data in a matter of hours.

In this webinar, you will learn:

  • The role of Parkinson's disease associated mutation p.D620N and other point mutations affecting VPS35 a protein linked to late onset autosomal dominant Parkinsonism
  • The changes in protein levels that take place during the dismantling and reorganization phases after traumatic brain injury. In particular ARC, I-Kappa beta and phosphorylated I-Kappa beta, Multidrug resistance protein (MRP)
  • How Simple Western is helping researchers drastically improve throughput, save time and sample and increase sensitivity in comparison with traditional Western blotting techniques


Simple Your Transgenic Plant and Cancer Pharmacodynamics Analysis / Research

October 22, 2014
Kristen A. McEachern, Ph.D., Scientist, Oncology Translational Science, AstraZeneca R&D Boston
Afshin Safavi, Ph.D., Founder and Chief Scientific Officer, BioAgilytix

One of the challenges that bioanalytical labs face when running protein analysis is the reproducibility and sensitivity of the methods used. This is particularly true when one needs to utilize traditional Western blotting techniques. Trying to identify phosphorylated and non-phosphorylated protein isoforms and being able to quantitate those isoforms is becoming a must-have for most researchers in pharmacodynamics analysis, but difficult to accomplish when relying on traditional techniques.

Learning objectives:

  • How the Simple Western platform integrates and automates all manual operations associated with Western blotting, from sample separation to quantitative data analysis
  • How to provide bioanalytical labs with reproducibility and sensitivity in their western blotting methods
  • How the Simple Western technology is applied to quantitative pharmacodynamics analysis in cancer research
  • How Simple Western provides tools to analyze proteins from 12 to 440 kDa, either by immunoassay or total protein analysis


Tackling the Challenges of Human Disease and Vaccine Research with Simple Western

September 24, 2014
Chris Esapa, PhD., Head of Protein Core Facility, Mammalian Genetics Unit, MRC Harwell
John Loughney, Scientist, Merck
Patricia Piatti, Ph.D., Simple Western Product Manager, ProteinSimple

Whether you are working with limited amounts of precious samples or bound by industry regulations requiring the detection of impurities in your end product, you have high expectations when it comes to sensitivity and reproducibility in the assays you run every day. Traditional techniques haven't exactly gotten you there because they are not only tedious but labor intensive and deliver data that is semi-quantitative at best—they also lack reproducibility and specificity.

Ready for a change? The Simple Western is a fully-automated assay that delivers sensitivity and reproducibility in a gel-free, blot-free and hands-free way. It is the complete reinvention of the traditional Western blot. Simple Western allows you to answer complex biological questions in protein research by offering highly reproducible quantitative data which ultimately addresses the challenges of other protein analysis techniques.

In this live webinar, speakers will describe a range of applications utilizing the Simple Western technology to overcome their research challenges and get the answers they need.

Chris Esapa, PhD. will open the discussion by presenting his first-hand experiences on the challenges of his projects in quantifying protein expression levels using traditional Western blot analysis due to availability of only minute amounts of tissues or lack of suitable reagents and technological platforms. Simple Western is helping in the study of molecular mechanisms using models of human disease enabling them to answer crucial scientific questions in disease processes relating to pathway analysis, and the role of post-translational modification such as phosphorylation, which is central to several of their research programs.

John Loughney will follow with a presentation on his vaccine development project hindered by the limitations of ELISA assays. He will describe how Simple Western has allowed his team to detect specific impurities in vaccine process purification with additional specificity by size separation and increased precision and reduced analyst bench work.

Lastly, you'll hear from the Simple Western product manager herself, Dr. Patricia Piatti on the latest Simple Western applications that will extend the Simple Western capabilities to new levels. You won't want to miss this!


Think You've Automated Your Western Workflow?

May 21, 2014
Catherine Hofler, Ph.D., Director of Research, Emerald Therapeutics
Andrea Tu, Ph.D., Application Scientist, ProteinSimple

Typical biomarker discovery involves screening many samples to identify potential targets. Western blotting has been the method of choice for many years to identify protein targets but it suffers from a highly tedious and labor-intensive manual process. Relatively little has been done to improve or automate the traditional Western workflow in the past 30 years until the introduction of the Simple Western, a fully automated and quantitative Western replacement system that makes your dream of never again having to run a protein gel or deal with messy blots come true.

In this webcast, Dr. Tu from ProteinSimple will describe how the Simple Western system, Wes, has not only automated, but transformed the old Western process from start to finish delivering reproducibility and quantitation like never before. Then, Dr. Hofler from Emerald Therapeutics will explain how the company incorporated the Simple Western into its automated workflow, enabling great scalability, reproducibility, and virtualization of the scientific process. Dr. Hofler will also share how the Simple Western allows her team to eliminate the time consuming and labor-intensive processes of protein detection by traditional Western blotting as they explore biologically complex phenomena such as apoptosis.

What You Will Learn:

  • How the Simple Western platform integrates and automates all manual operations associated with Western blotting
  • How the Simple Western platform can be integrated into a fully automated process that includes liquid handling, protein quantification, and sample preparation
  • How to increase efficiency of analytical testing and guide process development more effectively using the Simple Western system
  • How to explore cell signaling pathways and perform absolute quantitation of biomarkers using the Simple Western technology


Simple Your Process: Target Validation to Product Characterization

March 18, 2014
Zoran Sosic, Ph.D., Sr. Scientist, Biogen Idec
Richard Vivier, Research Scientist, Eli Lilly and Company, UK

Drug product characterization and target validation are critical steps in biopharmaceutical development. Both involve understanding the role of a certain biomolecule, such as protein, in a disease process. Traditionally, Western blots have been the default technology for confirming the presence or absence of a protein during these steps in drug development, but it suffers from a tedious and manual process that does not offer throughput or reproducibility. The Simple Western platform is the modern evolution of traditional immunoassay technologies and is uniquely suited to handle the rigorous needs of product characterization and drug target validation. It is a highly sensitive and fully automated system that is easy to use and accelerates the process by handling up to 96 samples in a single run. Further, Simple Western systems reduce variability to provide reproducible and fully quantitative data making product characterization and target validation easier and more efficient.

In this webcast, Dr. Sosic will describe how purified Fc-fusion recombinant protein was analyzed using Sally, a Simple Western system during product characterization and identification process. A side-by-side comparison of results from Simple Western and legacy Western blots will be demonstrated. Further, Mr. Vivier will provide examples of how the Simple Western system, Peggy, has been used for the characterization of animal models of neurodegeneration and how it can assist in the pharmacological validation of drug targets of cognition.


Understanding Brain Proteins and Developing High-Throughput Immunoassays Using the Simple Western

February 12, 2014
Hongming Chen, Ph.D., Principle Scientist, Merck & Co.
Deborah C. Mash, Ph.D., Professor of Neurobiology, Molecular and Cellular Pharmacology, University of Miami

Simple Western uses the principles of Western blotting, but is a fully automated walk-away solution that is a gel-free, blot-free, and hands-free reinvention of the traditional Western blot for protein separation and characterization. Simple Western is a valuable protein analysis technology for use in both assay development and basic research. Dr. Chen will discuss using Simple Western to facilitate development of a high-throughput immunoassay for IRAK1. Dr. Mash will use the same technology to quantitate specific proteins in postmortem human brain tissue.


Still Doing Westerns?

January 30, 2014
John Proctor, Ph.D., Director of Marketing, ProteinSimple

That's no fun! Well, it's time you learned about Wes, the latest gel-free, blot-free, hands-free reinvention of the traditional Western blot. Wes is a Simple Western instrument that delivers sensitivity and reproducibility that surpass the traditional Western and, for the first time, gives researchers a truly quantitative immunoassay for protein separation. Using a pre-filled microplate and a capillary cartridge, Wes also drastically reduces the hands-on time required when performing a traditional Western giving researchers fully analyzed data for up to 25 samples in under 3 hours. In this webinar, I will illustrate examples of how Wes and the Simple Western product family have been applied in protein expression and production, cell signaling analysis, biotherapeutic characterization, and vaccine research.


Still Think Westerns Are Just Qualitative?

August 13, 2013
Patricia Whaley, Ph.D., Product Manager, Simple Western, ProteinSimple

Traditional Western blotting produces major challenges that researchers face on a daily basis—unreliable data, delayed time to results, reduced productivity and, ultimately, more costly research programs.

Researchers WANT more when it comes to doing their research. The Simple Western platform is the modern evolution of traditional immunoassay techniques. The fully automated system can generate from 12 to 96 data points in a single experiment, handling low, medium or high throughput needs. Automation also removes variability, so results are more reproducible run to run, between users and over time. Since a blotting step is not performed, protein transfer inconsistencies are eliminated, providing more consistent and quantitative results. Removing all the manual steps saves valuable time that can be utilized for more important things. Since fully analyzed results are ready in less than 19 hours, experimental decisions can also be made much sooner.

Now, Researchers can DO more with Simple Western.


Biomarker Analysis Using the Simple Western Advances Pathogen Identification and Cancer Research

March 21, 2013
Philip Lorenzi, Ph.D., Surpervisor of Lab & Research, MD Anderson Cancer Center
David Hirschberg, Ph.D., Assistant Professor of Clinical Pathology, Columbia University
John Proctor, Ph.D., Director, Corporate Development, ProteinSimple

Biomarker discovery relies on the specific and accurate detection of protein targets that play key roles in regulatory response of pathogens as well as disease states in cancer cells and tissues. Immunodetection by Western blot analysis is a widely used technique to identify biomarkers involved in pathogen expression and cancer translational research. This technique has its challenges, namely unreliable data, semi-quantitative results, delayed time to results, reduced productivity and ultimately more costly research programs. ProteinSimple has introduced the Simple Western™, a novel capillary electrophoresis (CE) based immunodetection platform for protein separation by size or charge and characterization. It addresses the major challenges that researchers face with the traditional western blot. The Simple Western is a complete automated walk-away solution that is a gel-free, blot-free, and hands-free. In this webinar, participants will describe a range of applications utilizing the Simple Western technology. These applications address identification and characterization of emerging pathogens, and detection and quantitation of a key biomarker involved in acute lymphoblastic leukemia.


Approaches to the Use of Limited Clinical Material for Oncology Biomarker Study and Characterisation

February 28, 2013
Dr. Mark Aspinall-O'Dea, Postdoctoral Research Associate, Manchester University

The need for biomarkers or surrogate biomarkers in cancer and other diseases is pressing. Ethical and other issues, however, often limit the amount of material available for bioassay. We therefore developed methodologies appropriate for limited sample sizes deriving from clinical respiratory disease and cancer research. We have characterized a novel approach to this issue using the ProteinSimple's Simple Western charge assay run on the NanoPro 1000 capillary-immunoassay instrument. We have developed assays encompassing clinical samples from Chronic Myeloid Leukaemia (CML-SC), Chronic Lymphocytic Leukaemia (CLL), Non-Small Cell Lung Cancer (NSCLC; tissue & plasma) and Endometrial Cancer. This and other work with Protein Simple has defined the utility of the Simple Western charge assay in detailed mapping of signaling cascades in model systems and cellular organelles. A range of studies across these disease areas are currently ongoing for validation of disease and/or treatment markers in biopsy material and plasma. This includes work designed to extend our knowledge of aberrant post-translational events in human primary disease tissue samples as compared to control material. Furthermore, we have developed protocols for cross-platform analysis of samples to expedite results validation from high-end MS proteomic analysis creating a platform for validation/verification on small samples of clinical material.


Biotherapeutic Development is Hard: ProteinSimple Delivers Tools to Simplify the Process

December 4, 2012
John Proctor, Ph.D., Director, Corporate Development, ProteinSimple

In order to bring an antibody or other biologic drug to market, each step of the process needs to be carefully monitored. Charge heterogeneity and apparent MW via SDS-PAGE are two of the most commonly assessed parameters. Ideally, similar methods should be used from the beginning of development (low expression, complex matrix) to late in production and QC (high concentration, pure material). This enables comparison of early development findings to product release data.

Capillary-based techniques such as iCE and CE-SDS are currently heavily used in downstream product development, but pose challenges for small scale screening and characterization during cell culture and formulation development. In this webinar, we will discuss the latest Simple Western product, Peggy, which combines capillary electrophoresis with an immunoassay to provide highly reproducible and fully automated analysis of monoclonal antibodies.

This sensitive instrument measures either size or charge in complex samples and provides critical charge heterogeneity, size, and product titer information without the need for sample purification. Data will be presented demonstrating the complimentarity of the Simple Western assay and the iCE technology for the analysis of monoclonal antibodies against VEGF and the ability of the two techniques to provide consistency of data across a product development program.


The Simple Western: A Fully Automated, Quantitative Alternative to the Traditional Western Blot

November 6, 2012
David Voehringer, Ph.D., Sales Director, ProteinSimple

Tired of running gels and washing blots? ProteinSimple has introduced the Simple Western, a fully automated walk-away solution that is a gel-free, blot-free, and hands-free reinvention of the Western blot for protein separation and characterization. It delivers reproducibility and true quantitation while addressing the major challenges that researchers face on a daily basis—unreliable data, delayed time to results, reduced productivity and, ultimately, more costly research programs. Whether you're doing protein research in biotech, pharma, or academia there is a Simple Western application for you. Join us to learn more about the instruments that run Simple Western assays and see for yourself some of the possibilities in protein, vaccine and clinical research.


The Simple Western Approach to Vaccine and Clinical Protein Research

October 4, 2012
Peter Fung, Ph.D., Product Manager, ProteinSimple
Melissa Hamm, Research Biochemist, Vaccine Analytical Development, Merk & Co.
Alice Fan, M.D., Instructor, Medicine and Oncology, Stanford University School of Medicine

The Simple Western addresses the major challenges that researchers face on a daily basis—unreliable data, delayed time to results, reduced productivity and, ultimately, more costly research programs. The Simple Western is a completely automated walk-away solution that is a gel-free, blot-free, and hands-free reinvention of the Western blot. In this webinar, a range of applications including protein vaccine development, and identification and quantitation of tumor-associated proteins in precious clinical samples are presented.


Simple Western Platform Introduction

July 20, 2012
John Proctor, Ph.D., Director, Corporate Development, ProteinSimple

The SimpleWestern Platform is the modern evolution of traditional immunoassay techniques. Using robust capillary electrophoresis technology, each system delivers size-based separation, immunodetection, and precise quantitation for protein-based applications all with minimal input from the user in an easy to use walk-away design. Do more with the Simple Western.